 Henry Galan
Concepts (522)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetal Growth Retardation | 51 | 2025 | 565 | 6.980 |
Why?
| | Ultrasonography, Prenatal | 37 | 2024 | 284 | 4.260 |
Why?
| | Placenta | 29 | 2022 | 749 | 2.730 |
Why?
| | Pregnancy | 109 | 2025 | 6743 | 2.640 |
Why?
| | Ultrasonography, Doppler | 19 | 2023 | 123 | 2.620 |
Why?
| | Umbilical Arteries | 12 | 2023 | 54 | 2.380 |
Why?
| | Fetofetal Transfusion | 5 | 2025 | 26 | 1.950 |
Why?
| | Gestational Age | 37 | 2024 | 902 | 1.820 |
Why?
| | Gynecology | 4 | 2022 | 176 | 1.500 |
Why?
| | Uterine Artery | 6 | 2020 | 79 | 1.480 |
Why?
| | Fetus | 24 | 2023 | 806 | 1.450 |
Why?
| | Sheep | 27 | 2017 | 855 | 1.400 |
Why?
| | Laser Coagulation | 2 | 2025 | 68 | 1.400 |
Why?
| | Pregnancy Outcome | 11 | 2024 | 411 | 1.360 |
Why?
| | Meningomyelocele | 5 | 2022 | 59 | 1.270 |
Why?
| | Fetal Weight | 7 | 2022 | 56 | 1.190 |
Why?
| | Fetoscopy | 4 | 2025 | 30 | 1.170 |
Why?
| | Pregnancy, Twin | 4 | 2022 | 19 | 1.170 |
Why?
| | Obstetrics | 6 | 2022 | 163 | 1.070 |
Why?
| | Fetal Diseases | 7 | 2024 | 173 | 1.050 |
Why?
| | Infant, Newborn | 36 | 2024 | 6054 | 0.990 |
Why?
| | Infant, Small for Gestational Age | 7 | 2022 | 91 | 0.940 |
Why?
| | Female | 115 | 2025 | 73052 | 0.940 |
Why?
| | Fetal Development | 3 | 2021 | 296 | 0.930 |
Why?
| | Inositol | 5 | 2014 | 26 | 0.850 |
Why?
| | Delivery, Obstetric | 5 | 2021 | 145 | 0.800 |
Why?
| | Sorbitol | 4 | 2014 | 14 | 0.760 |
Why?
| | Nitric Oxide Synthase Type III | 6 | 2011 | 204 | 0.750 |
Why?
| | Comorbidity | 2 | 2024 | 1624 | 0.740 |
Why?
| | Umbilical Veins | 6 | 2009 | 61 | 0.700 |
Why?
| | Hydrocephalus | 4 | 2024 | 106 | 0.700 |
Why?
| | Pregnancy Complications | 7 | 2024 | 525 | 0.680 |
Why?
| | Cerclage, Cervical | 2 | 2022 | 6 | 0.680 |
Why?
| | Infant, Newborn, Diseases | 1 | 2022 | 113 | 0.680 |
Why?
| | Hernias, Diaphragmatic, Congenital | 4 | 2024 | 201 | 0.660 |
Why?
| | X-Linked Inhibitor of Apoptosis Protein | 2 | 2010 | 12 | 0.640 |
Why?
| | Uterine Cervical Incompetence | 1 | 2019 | 3 | 0.640 |
Why?
| | Altitude | 4 | 2013 | 485 | 0.610 |
Why?
| | Pregnancy, Animal | 4 | 2012 | 52 | 0.600 |
Why?
| | Pre-Eclampsia | 4 | 2015 | 189 | 0.580 |
Why?
| | Placental Insufficiency | 7 | 2017 | 116 | 0.580 |
Why?
| | Birth Weight | 9 | 2021 | 515 | 0.580 |
Why?
| | Humans | 95 | 2025 | 137294 | 0.570 |
Why?
| | Amniotic Fluid | 8 | 2024 | 96 | 0.560 |
Why?
| | Atrioventricular Block | 1 | 2017 | 37 | 0.530 |
Why?
| | Bradycardia | 1 | 2017 | 55 | 0.530 |
Why?
| | Regional Blood Flow | 8 | 2011 | 474 | 0.520 |
Why?
| | Internship and Residency | 3 | 2022 | 1137 | 0.520 |
Why?
| | Prenatal Diagnosis | 5 | 2024 | 202 | 0.510 |
Why?
| | Blood Flow Velocity | 7 | 2022 | 412 | 0.510 |
Why?
| | Maternal-Fetal Exchange | 8 | 2021 | 165 | 0.490 |
Why?
| | Body Composition | 5 | 2022 | 678 | 0.480 |
Why?
| | Uterus | 3 | 2011 | 215 | 0.450 |
Why?
| | Adipose Tissue | 3 | 2016 | 630 | 0.450 |
Why?
| | Amino Acids | 4 | 2021 | 501 | 0.430 |
Why?
| | Premature Birth | 5 | 2024 | 331 | 0.430 |
Why?
| | Fetal Therapies | 5 | 2024 | 40 | 0.430 |
Why?
| | Disease Models, Animal | 15 | 2021 | 4284 | 0.420 |
Why?
| | Nitric Oxide Synthase | 3 | 2006 | 240 | 0.420 |
Why?
| | Nitric Oxide | 7 | 2011 | 915 | 0.420 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 3 | 2014 | 171 | 0.420 |
Why?
| | Opioid-Related Disorders | 1 | 2020 | 506 | 0.400 |
Why?
| | Puerperal Disorders | 2 | 2008 | 32 | 0.400 |
Why?
| | Laser-Doppler Flowmetry | 3 | 2005 | 32 | 0.390 |
Why?
| | Pulsatile Flow | 7 | 2011 | 60 | 0.390 |
Why?
| | NFATC Transcription Factors | 1 | 2012 | 95 | 0.370 |
Why?
| | Iron-Dextran Complex | 2 | 2003 | 7 | 0.350 |
Why?
| | Apoptosis | 5 | 2017 | 2554 | 0.350 |
Why?
| | Blood Pressure | 4 | 2017 | 1776 | 0.350 |
Why?
| | Organ Size | 11 | 2015 | 477 | 0.340 |
Why?
| | Biometry | 2 | 2008 | 70 | 0.340 |
Why?
| | Retrospective Studies | 18 | 2024 | 15639 | 0.340 |
Why?
| | Amniocentesis | 4 | 2019 | 25 | 0.330 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2009 | 39 | 0.330 |
Why?
| | Gastroschisis | 2 | 2020 | 25 | 0.320 |
Why?
| | Hemodynamics | 8 | 2009 | 1110 | 0.320 |
Why?
| | Pregnancy Reduction, Multifetal | 2 | 2021 | 5 | 0.320 |
Why?
| | Caspase 3 | 1 | 2010 | 246 | 0.320 |
Why?
| | Adult | 30 | 2025 | 37724 | 0.320 |
Why?
| | Lung | 13 | 2024 | 4067 | 0.310 |
Why?
| | Fetal Blood | 4 | 2024 | 327 | 0.310 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2011 | 436 | 0.310 |
Why?
| | Prospective Studies | 10 | 2025 | 7595 | 0.310 |
Why?
| | Polycythemia | 2 | 2021 | 21 | 0.310 |
Why?
| | Amino Acids, Essential | 1 | 2008 | 13 | 0.310 |
Why?
| | Heart Rate | 2 | 2012 | 823 | 0.290 |
Why?
| | Animals | 41 | 2021 | 36862 | 0.290 |
Why?
| | Iliac Vein | 1 | 2008 | 13 | 0.290 |
Why?
| | Nutritional Status | 1 | 2010 | 344 | 0.280 |
Why?
| | Twins, Monozygotic | 2 | 2021 | 212 | 0.280 |
Why?
| | Papio | 5 | 2021 | 93 | 0.280 |
Why?
| | Femoral Vein | 1 | 2008 | 34 | 0.280 |
Why?
| | Iliac Artery | 1 | 2008 | 55 | 0.280 |
Why?
| | Dystocia | 1 | 2007 | 11 | 0.280 |
Why?
| | Protein Kinases | 1 | 2009 | 319 | 0.270 |
Why?
| | Pregnancy Trimester, Third | 5 | 2024 | 114 | 0.260 |
Why?
| | MicroRNAs | 2 | 2024 | 699 | 0.250 |
Why?
| | Polyhydramnios | 2 | 2023 | 17 | 0.250 |
Why?
| | Risk Factors | 9 | 2025 | 10368 | 0.250 |
Why?
| | Venous Thrombosis | 1 | 2008 | 190 | 0.240 |
Why?
| | Airway Obstruction | 2 | 2020 | 162 | 0.240 |
Why?
| | Transcription Factors | 2 | 2014 | 1720 | 0.240 |
Why?
| | Retroviridae | 2 | 2002 | 99 | 0.240 |
Why?
| | Trophoblasts | 5 | 2015 | 199 | 0.230 |
Why?
| | Fellowships and Scholarships | 2 | 2018 | 306 | 0.220 |
Why?
| | Bartter Syndrome | 1 | 2023 | 8 | 0.220 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 2 | 2018 | 350 | 0.210 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2004 | 77 | 0.210 |
Why?
| | Asphyxia | 1 | 2003 | 20 | 0.210 |
Why?
| | Hernia, Umbilical | 1 | 2023 | 17 | 0.210 |
Why?
| | RNA, Messenger | 7 | 2012 | 2839 | 0.210 |
Why?
| | Prenatal Care | 4 | 2022 | 288 | 0.210 |
Why?
| | Fever | 6 | 2009 | 308 | 0.210 |
Why?
| | Pregnancy Proteins | 2 | 2015 | 36 | 0.200 |
Why?
| | Abortion, Spontaneous | 1 | 2023 | 105 | 0.200 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2024 | 121 | 0.200 |
Why?
| | Models, Animal | 3 | 2012 | 384 | 0.200 |
Why?
| | Transduction, Genetic | 2 | 2002 | 126 | 0.200 |
Why?
| | Osmolar Concentration | 3 | 2014 | 171 | 0.200 |
Why?
| | Pulmonary Surfactants | 2 | 1993 | 106 | 0.190 |
Why?
| | Fetal Monitoring | 1 | 2002 | 15 | 0.190 |
Why?
| | Uterine Cervical Diseases | 1 | 2022 | 6 | 0.190 |
Why?
| | Blood Vessels | 2 | 2000 | 187 | 0.190 |
Why?
| | Blood Circulation | 1 | 2002 | 41 | 0.190 |
Why?
| | Meconium | 1 | 2001 | 7 | 0.190 |
Why?
| | Meconium Aspiration Syndrome | 1 | 2001 | 11 | 0.190 |
Why?
| | Cervix Uteri | 1 | 2022 | 49 | 0.190 |
Why?
| | Genetic Vectors | 2 | 2002 | 321 | 0.190 |
Why?
| | Aspirin | 2 | 2015 | 387 | 0.180 |
Why?
| | Diet, Protein-Restricted | 1 | 2021 | 11 | 0.180 |
Why?
| | Hot Temperature | 3 | 2014 | 394 | 0.180 |
Why?
| | Rheology | 1 | 2022 | 91 | 0.180 |
Why?
| | Amino Acid Transport System L | 1 | 2021 | 19 | 0.180 |
Why?
| | Emergencies | 1 | 2022 | 165 | 0.180 |
Why?
| | Case-Control Studies | 6 | 2024 | 3546 | 0.180 |
Why?
| | Embryonic and Fetal Development | 5 | 2002 | 97 | 0.180 |
Why?
| | Infant | 8 | 2023 | 9451 | 0.180 |
Why?
| | Nasopharynx | 1 | 2001 | 76 | 0.180 |
Why?
| | Amino Acid Transport System A | 1 | 2021 | 37 | 0.180 |
Why?
| | Retrognathia | 1 | 2020 | 5 | 0.180 |
Why?
| | Fetal Death | 3 | 2023 | 55 | 0.170 |
Why?
| | Biomarkers | 4 | 2024 | 4164 | 0.170 |
Why?
| | Sensitivity and Specificity | 6 | 2015 | 1946 | 0.170 |
Why?
| | Bupivacaine | 1 | 2020 | 32 | 0.170 |
Why?
| | Arm | 2 | 2016 | 104 | 0.170 |
Why?
| | Heart Diseases | 1 | 2004 | 359 | 0.170 |
Why?
| | Micrognathism | 1 | 2020 | 18 | 0.170 |
Why?
| | Twins, Dizygotic | 1 | 2021 | 183 | 0.170 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2023 | 257 | 0.170 |
Why?
| | Umbilical Cord | 5 | 2010 | 85 | 0.170 |
Why?
| | Anesthetics, Local | 1 | 2020 | 80 | 0.170 |
Why?
| | Respiration | 4 | 2006 | 198 | 0.170 |
Why?
| | Myometrium | 2 | 2011 | 39 | 0.170 |
Why?
| | Ductus Arteriosus | 3 | 2018 | 73 | 0.160 |
Why?
| | Goats | 1 | 1999 | 27 | 0.160 |
Why?
| | Respiratory Distress Syndrome, Newborn | 3 | 1999 | 106 | 0.160 |
Why?
| | Endothelium, Vascular | 1 | 2006 | 927 | 0.160 |
Why?
| | Anemia | 1 | 2021 | 170 | 0.160 |
Why?
| | Leg | 2 | 2016 | 236 | 0.160 |
Why?
| | Obstetric Surgical Procedures | 1 | 2019 | 6 | 0.160 |
Why?
| | Registries | 2 | 2025 | 2016 | 0.160 |
Why?
| | Pregnancy Trimester, Second | 3 | 2017 | 80 | 0.150 |
Why?
| | Reference Values | 4 | 2008 | 818 | 0.150 |
Why?
| | Maternal Health | 1 | 2019 | 49 | 0.150 |
Why?
| | Immunohistochemistry | 4 | 2010 | 1734 | 0.150 |
Why?
| | Tocolytic Agents | 1 | 2018 | 16 | 0.150 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2022 | 292 | 0.150 |
Why?
| | Indomethacin | 1 | 2018 | 81 | 0.150 |
Why?
| | Time Factors | 8 | 2019 | 6818 | 0.150 |
Why?
| | Colorado | 7 | 2020 | 4527 | 0.140 |
Why?
| | Pain, Postoperative | 1 | 2020 | 270 | 0.140 |
Why?
| | Maternal Exposure | 1 | 2020 | 188 | 0.140 |
Why?
| | Biological Transport | 3 | 2021 | 417 | 0.140 |
Why?
| | Hyaline Membrane Disease | 2 | 1997 | 20 | 0.140 |
Why?
| | Hysterotomy | 1 | 2017 | 9 | 0.140 |
Why?
| | Cesarean Section | 3 | 2024 | 185 | 0.140 |
Why?
| | Duodenal Obstruction | 1 | 2017 | 4 | 0.140 |
Why?
| | Antibiotic Prophylaxis | 2 | 2011 | 117 | 0.140 |
Why?
| | Cardiomyopathies | 1 | 2021 | 350 | 0.140 |
Why?
| | Esophageal Atresia | 1 | 2017 | 26 | 0.130 |
Why?
| | Paralysis | 1 | 1997 | 70 | 0.130 |
Why?
| | Heart Defects, Congenital | 1 | 2024 | 834 | 0.130 |
Why?
| | Body Mass Index | 3 | 2019 | 2373 | 0.130 |
Why?
| | Attitude | 1 | 2018 | 260 | 0.130 |
Why?
| | Intracranial Embolism and Thrombosis | 1 | 1995 | 6 | 0.130 |
Why?
| | Protein S Deficiency | 1 | 1995 | 7 | 0.120 |
Why?
| | Caspases | 1 | 2017 | 247 | 0.120 |
Why?
| | Placental Circulation | 3 | 2012 | 71 | 0.120 |
Why?
| | Aldehyde Reductase | 2 | 2014 | 29 | 0.120 |
Why?
| | Lateral Ventricles | 1 | 2016 | 35 | 0.120 |
Why?
| | Magnetic Resonance Imaging | 5 | 2024 | 3568 | 0.120 |
Why?
| | Blotting, Western | 4 | 2011 | 1226 | 0.120 |
Why?
| | Curriculum | 1 | 2022 | 983 | 0.120 |
Why?
| | Symporters | 2 | 2014 | 67 | 0.120 |
Why?
| | Hypertension | 1 | 2005 | 1285 | 0.120 |
Why?
| | Mannose | 2 | 2012 | 24 | 0.120 |
Why?
| | Hypertension, Pulmonary | 3 | 2022 | 1904 | 0.120 |
Why?
| | Coronary Circulation | 1 | 2015 | 141 | 0.120 |
Why?
| | Choriocarcinoma | 1 | 2014 | 9 | 0.110 |
Why?
| | Fetal Heart | 1 | 2015 | 55 | 0.110 |
Why?
| | Saline Solution, Hypertonic | 1 | 2014 | 41 | 0.110 |
Why?
| | Metformin | 1 | 2018 | 330 | 0.110 |
Why?
| | Regression Analysis | 3 | 2008 | 1028 | 0.110 |
Why?
| | Sheep Diseases | 1 | 2014 | 8 | 0.110 |
Why?
| | Cohort Studies | 4 | 2020 | 5726 | 0.110 |
Why?
| | HSP27 Heat-Shock Proteins | 1 | 2014 | 14 | 0.110 |
Why?
| | Calcium | 2 | 2011 | 1198 | 0.110 |
Why?
| | Bronchogenic Cyst | 1 | 2013 | 7 | 0.110 |
Why?
| | Caloric Restriction | 1 | 2015 | 123 | 0.110 |
Why?
| | Down-Regulation | 3 | 2021 | 658 | 0.110 |
Why?
| | Diabetes, Gestational | 1 | 2018 | 316 | 0.110 |
Why?
| | Pilot Projects | 3 | 2020 | 1700 | 0.110 |
Why?
| | Young Adult | 6 | 2021 | 13163 | 0.100 |
Why?
| | Ultrasonography | 2 | 2022 | 752 | 0.100 |
Why?
| | Body Weights and Measures | 1 | 2013 | 36 | 0.100 |
Why?
| | Coronary Vessels | 1 | 2015 | 246 | 0.100 |
Why?
| | Uterine Neoplasms | 1 | 2014 | 109 | 0.100 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2010 | 858 | 0.100 |
Why?
| | Umbilicus | 1 | 2013 | 18 | 0.100 |
Why?
| | Fatty Alcohols | 1 | 1992 | 5 | 0.100 |
Why?
| | Rabbits | 3 | 2003 | 793 | 0.100 |
Why?
| | Phosphorylcholine | 1 | 1992 | 20 | 0.100 |
Why?
| | Amnion | 1 | 1992 | 28 | 0.100 |
Why?
| | Longitudinal Studies | 3 | 2013 | 2850 | 0.100 |
Why?
| | Analgesics, Opioid | 1 | 2020 | 994 | 0.100 |
Why?
| | Femur | 3 | 2008 | 258 | 0.100 |
Why?
| | Lung Volume Measurements | 2 | 2023 | 46 | 0.100 |
Why?
| | NADP | 1 | 2012 | 50 | 0.100 |
Why?
| | Signal Transduction | 4 | 2011 | 5078 | 0.100 |
Why?
| | Calcium Signaling | 2 | 2011 | 249 | 0.090 |
Why?
| | Isotope Labeling | 1 | 2012 | 80 | 0.090 |
Why?
| | Animals, Newborn | 5 | 2000 | 844 | 0.090 |
Why?
| | Estradiol | 3 | 2000 | 518 | 0.090 |
Why?
| | Practice Guidelines as Topic | 2 | 2018 | 1577 | 0.090 |
Why?
| | Muscle, Skeletal | 1 | 2001 | 1709 | 0.090 |
Why?
| | Blood Volume | 1 | 2011 | 61 | 0.090 |
Why?
| | Pregnancy-Associated Plasma Protein-A | 1 | 2010 | 14 | 0.090 |
Why?
| | Pregnancy Trimesters | 1 | 2010 | 19 | 0.090 |
Why?
| | Keratin-18 | 1 | 2010 | 10 | 0.090 |
Why?
| | Abdomen | 2 | 2003 | 125 | 0.090 |
Why?
| | Galectins | 1 | 2010 | 24 | 0.090 |
Why?
| | Probability | 2 | 2001 | 309 | 0.090 |
Why?
| | Chorionic Villi | 1 | 2010 | 25 | 0.090 |
Why?
| | Calcium Channels | 1 | 2011 | 159 | 0.080 |
Why?
| | Carbohydrate Metabolism | 1 | 2010 | 61 | 0.080 |
Why?
| | Clinical Competence | 1 | 2018 | 1100 | 0.080 |
Why?
| | Carbohydrates | 1 | 2010 | 67 | 0.080 |
Why?
| | Cell Hypoxia | 1 | 2011 | 226 | 0.080 |
Why?
| | Oxygen | 4 | 2008 | 935 | 0.080 |
Why?
| | Diagnostic Techniques, Cardiovascular | 1 | 2009 | 11 | 0.080 |
Why?
| | Term Birth | 1 | 2009 | 23 | 0.080 |
Why?
| | Infant, Premature | 2 | 2012 | 567 | 0.080 |
Why?
| | TRPC Cation Channels | 1 | 2009 | 14 | 0.080 |
Why?
| | Diglycerides | 1 | 2009 | 61 | 0.080 |
Why?
| | High-Frequency Ventilation | 2 | 1999 | 45 | 0.080 |
Why?
| | Hypoglycemic Agents | 1 | 2018 | 1283 | 0.080 |
Why?
| | Cordocentesis | 1 | 2008 | 1 | 0.080 |
Why?
| | Middle Cerebral Artery | 1 | 2009 | 53 | 0.080 |
Why?
| | Angiography | 1 | 2009 | 207 | 0.080 |
Why?
| | Hyperthermia, Induced | 1 | 2010 | 116 | 0.080 |
Why?
| | Endoplasmic Reticulum | 1 | 2011 | 264 | 0.070 |
Why?
| | Crown-Rump Length | 1 | 2008 | 3 | 0.070 |
Why?
| | Endothelin-1 | 2 | 2008 | 182 | 0.070 |
Why?
| | Blood Gas Analysis | 1 | 2008 | 74 | 0.070 |
Why?
| | Placenta Diseases | 1 | 2008 | 18 | 0.070 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2008 | 38 | 0.070 |
Why?
| | Birth Injuries | 1 | 2007 | 9 | 0.070 |
Why?
| | Fluorocarbons | 2 | 1999 | 117 | 0.070 |
Why?
| | Polyethylene Glycols | 1 | 1992 | 640 | 0.070 |
Why?
| | Foot | 1 | 2008 | 97 | 0.070 |
Why?
| | Pulmonary Circulation | 2 | 2000 | 430 | 0.070 |
Why?
| | Syndrome | 1 | 2008 | 357 | 0.070 |
Why?
| | Shoulder | 1 | 2007 | 89 | 0.070 |
Why?
| | Body Weight | 3 | 2006 | 985 | 0.060 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2009 | 412 | 0.060 |
Why?
| | Sheep, Domestic | 1 | 2006 | 34 | 0.060 |
Why?
| | Risk | 1 | 2009 | 908 | 0.060 |
Why?
| | Glucose Transporter Type 4 | 1 | 2006 | 40 | 0.060 |
Why?
| | Polymers | 1 | 2010 | 491 | 0.060 |
Why?
| | Glucose Transporter Type 1 | 1 | 2006 | 50 | 0.060 |
Why?
| | Models, Theoretical | 1 | 2009 | 575 | 0.060 |
Why?
| | Fetal Hypoxia | 1 | 2006 | 54 | 0.060 |
Why?
| | Imaging, Three-Dimensional | 1 | 2009 | 577 | 0.060 |
Why?
| | Obesity | 1 | 2019 | 2983 | 0.060 |
Why?
| | Infant, Premature, Diseases | 1 | 2007 | 100 | 0.060 |
Why?
| | Vasodilation | 2 | 2000 | 496 | 0.060 |
Why?
| | Biophysics | 1 | 2006 | 69 | 0.060 |
Why?
| | Echocardiography | 2 | 2021 | 659 | 0.060 |
Why?
| | Receptors, Growth Factor | 2 | 2002 | 55 | 0.060 |
Why?
| | Cerebral Aqueduct | 1 | 2024 | 4 | 0.060 |
Why?
| | Labor, Obstetric | 1 | 2004 | 61 | 0.050 |
Why?
| | Cells, Cultured | 4 | 2014 | 4197 | 0.050 |
Why?
| | Body Size | 1 | 2004 | 108 | 0.050 |
Why?
| | Potassium Chloride | 1 | 2003 | 38 | 0.050 |
Why?
| | Self Report | 2 | 2018 | 826 | 0.050 |
Why?
| | Heat-Shock Proteins | 2 | 2014 | 142 | 0.050 |
Why?
| | Up-Regulation | 1 | 2006 | 844 | 0.050 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2003 | 544 | 0.050 |
Why?
| | Fetal Movement | 2 | 2006 | 6 | 0.050 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2003 | 108 | 0.050 |
Why?
| | Brain Diseases | 1 | 2004 | 141 | 0.050 |
Why?
| | In Situ Nick-End Labeling | 2 | 2014 | 124 | 0.050 |
Why?
| | Cardiovascular Agents | 1 | 2004 | 160 | 0.050 |
Why?
| | Morbidity | 1 | 2023 | 324 | 0.050 |
Why?
| | beta-Galactosidase | 1 | 2002 | 78 | 0.050 |
Why?
| | Polymerase Chain Reaction | 2 | 2002 | 1061 | 0.050 |
Why?
| | Face | 1 | 2003 | 173 | 0.050 |
Why?
| | Cerebral Palsy | 1 | 2004 | 107 | 0.050 |
Why?
| | Endothelial Growth Factors | 1 | 2002 | 64 | 0.050 |
Why?
| | Apgar Score | 1 | 2001 | 17 | 0.050 |
Why?
| | Lymphokines | 1 | 2002 | 131 | 0.050 |
Why?
| | Perineum | 1 | 2001 | 32 | 0.050 |
Why?
| | Constriction | 2 | 2018 | 48 | 0.050 |
Why?
| | Bone and Bones | 1 | 2004 | 316 | 0.050 |
Why?
| | Light Coagulation | 1 | 2021 | 8 | 0.050 |
Why?
| | Suction | 1 | 2001 | 34 | 0.050 |
Why?
| | Italy | 1 | 2001 | 109 | 0.050 |
Why?
| | Laparoscopy | 2 | 1997 | 464 | 0.050 |
Why?
| | Algorithms | 1 | 2009 | 1692 | 0.040 |
Why?
| | Endpoint Determination | 1 | 2001 | 77 | 0.040 |
Why?
| | Antigens, Neoplasm | 1 | 2023 | 320 | 0.040 |
Why?
| | Receptors, Cell Surface | 1 | 2003 | 386 | 0.040 |
Why?
| | Treatment Outcome | 4 | 2019 | 10800 | 0.040 |
Why?
| | Myocardium | 1 | 2006 | 1002 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2023 | 429 | 0.040 |
Why?
| | Protein Biosynthesis | 1 | 2003 | 434 | 0.040 |
Why?
| | Drainage | 1 | 2021 | 171 | 0.040 |
Why?
| | Gene Transfer Techniques | 1 | 2001 | 169 | 0.040 |
Why?
| | Predictive Value of Tests | 3 | 2015 | 2032 | 0.040 |
Why?
| | Airway Management | 1 | 2020 | 52 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2003 | 696 | 0.040 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2020 | 132 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2021 | 497 | 0.040 |
Why?
| | Gastrostomy | 1 | 2021 | 112 | 0.040 |
Why?
| | Maternal Age | 1 | 2020 | 129 | 0.040 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2021 | 176 | 0.040 |
Why?
| | Parietal Bone | 1 | 1999 | 8 | 0.040 |
Why?
| | Diffusion | 1 | 1999 | 119 | 0.040 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2019 | 36 | 0.040 |
Why?
| | Perinatal Death | 1 | 2019 | 25 | 0.040 |
Why?
| | Pulmonary Artery | 3 | 2000 | 1084 | 0.040 |
Why?
| | Arteries | 1 | 2000 | 269 | 0.040 |
Why?
| | Insulin | 2 | 2006 | 2406 | 0.040 |
Why?
| | Anthropometry | 1 | 1999 | 213 | 0.040 |
Why?
| | Linear Models | 2 | 2017 | 846 | 0.040 |
Why?
| | Cigarette Smoking | 1 | 2020 | 101 | 0.040 |
Why?
| | Male | 6 | 2012 | 67560 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2007 | 976 | 0.040 |
Why?
| | Phosphorylation | 2 | 2014 | 1759 | 0.040 |
Why?
| | Pancuronium | 1 | 1997 | 4 | 0.030 |
Why?
| | Bronchodilator Agents | 1 | 1999 | 248 | 0.030 |
Why?
| | Neuromuscular Depolarizing Agents | 1 | 1997 | 4 | 0.030 |
Why?
| | Tibia | 1 | 1999 | 181 | 0.030 |
Why?
| | Obstetric Labor, Premature | 1 | 1997 | 36 | 0.030 |
Why?
| | Survival Rate | 1 | 2022 | 1970 | 0.030 |
Why?
| | Enteral Nutrition | 1 | 2019 | 201 | 0.030 |
Why?
| | Respiration, Artificial | 2 | 1999 | 643 | 0.030 |
Why?
| | Intestinal Atresia | 1 | 2017 | 14 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2017 | 5125 | 0.030 |
Why?
| | Endothelin Receptor Antagonists | 1 | 1997 | 62 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 1998 | 431 | 0.030 |
Why?
| | Injections, Intramuscular | 1 | 1997 | 126 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2018 | 2052 | 0.030 |
Why?
| | Pulmonary Edema | 1 | 1997 | 107 | 0.030 |
Why?
| | Capillary Permeability | 1 | 1997 | 145 | 0.030 |
Why?
| | Genetic Counseling | 1 | 2017 | 78 | 0.030 |
Why?
| | Administration, Inhalation | 4 | 1999 | 683 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2017 | 156 | 0.030 |
Why?
| | Excitatory Amino Acids | 1 | 2015 | 7 | 0.030 |
Why?
| | Length of Stay | 1 | 2001 | 1218 | 0.030 |
Why?
| | Insufflation | 1 | 1995 | 12 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2022 | 1464 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2004 | 5436 | 0.030 |
Why?
| | Transport Vesicles | 1 | 2015 | 18 | 0.030 |
Why?
| | Proteins | 1 | 2002 | 1012 | 0.030 |
Why?
| | Biological Transport, Active | 1 | 2015 | 77 | 0.030 |
Why?
| | United States | 3 | 2018 | 14742 | 0.030 |
Why?
| | Placenta Growth Factor | 1 | 2015 | 24 | 0.030 |
Why?
| | Bone Marrow Transplantation | 1 | 1997 | 287 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2000 | 1318 | 0.030 |
Why?
| | Twins | 1 | 2017 | 253 | 0.030 |
Why?
| | Saimiri | 1 | 1995 | 9 | 0.030 |
Why?
| | Aorta | 1 | 1998 | 417 | 0.030 |
Why?
| | Uterine Prolapse | 1 | 1995 | 14 | 0.030 |
Why?
| | Carbon Dioxide | 2 | 1995 | 267 | 0.030 |
Why?
| | Urethral Diseases | 1 | 1995 | 19 | 0.030 |
Why?
| | Neutrophils | 2 | 1999 | 1236 | 0.030 |
Why?
| | Genetic Therapy | 1 | 1997 | 296 | 0.030 |
Why?
| | Sterilization, Tubal | 1 | 1994 | 16 | 0.030 |
Why?
| | Pelvic Inflammatory Disease | 1 | 1994 | 11 | 0.030 |
Why?
| | DNA Fragmentation | 1 | 2014 | 41 | 0.030 |
Why?
| | Societies, Medical | 1 | 2018 | 822 | 0.030 |
Why?
| | Health Status | 1 | 2019 | 789 | 0.030 |
Why?
| | Thoracotomy | 1 | 2013 | 75 | 0.030 |
Why?
| | Program Evaluation | 1 | 2018 | 891 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1521 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2836 | 0.030 |
Why?
| | Pregnancy in Diabetics | 1 | 1995 | 122 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2014 | 1089 | 0.020 |
Why?
| | Molecular Chaperones | 1 | 2014 | 195 | 0.020 |
Why?
| | Surveys and Questionnaires | 3 | 2018 | 5769 | 0.020 |
Why?
| | Injections | 1 | 1992 | 183 | 0.020 |
Why?
| | Hydrogen | 1 | 2012 | 72 | 0.020 |
Why?
| | Heart Rate, Fetal | 2 | 2006 | 21 | 0.020 |
Why?
| | Logistic Models | 1 | 2017 | 2071 | 0.020 |
Why?
| | Carbon Isotopes | 1 | 2012 | 145 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 1993 | 596 | 0.020 |
Why?
| | Drug Combinations | 1 | 1992 | 344 | 0.020 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 1997 | 615 | 0.020 |
Why?
| | Radiography | 1 | 1993 | 832 | 0.020 |
Why?
| | Anticoagulants | 1 | 1995 | 662 | 0.020 |
Why?
| | Myo-Inositol-1-Phosphate Synthase | 1 | 2010 | 2 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 153 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2015 | 1985 | 0.020 |
Why?
| | Gene Silencing | 1 | 2011 | 195 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 186 | 0.020 |
Why?
| | TRPC6 Cation Channel | 1 | 2009 | 3 | 0.020 |
Why?
| | Fructose | 1 | 2010 | 112 | 0.020 |
Why?
| | Intracellular Space | 1 | 2009 | 68 | 0.020 |
Why?
| | Risk Assessment | 1 | 2019 | 3439 | 0.020 |
Why?
| | Efficiency | 1 | 2009 | 99 | 0.020 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2011 | 220 | 0.020 |
Why?
| | Ultrasonography, Doppler, Pulsed | 1 | 2008 | 7 | 0.020 |
Why?
| | Sodium | 1 | 2009 | 217 | 0.020 |
Why?
| | Pulmonary Gas Exchange | 2 | 1999 | 121 | 0.020 |
Why?
| | Head | 1 | 2008 | 105 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2009 | 622 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2009 | 363 | 0.020 |
Why?
| | Adolescent | 3 | 2017 | 21499 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2019 | 2658 | 0.020 |
Why?
| | Partial Pressure | 1 | 2006 | 30 | 0.020 |
Why?
| | Heating | 1 | 2006 | 23 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2007 | 284 | 0.020 |
Why?
| | Insulin Receptor Substrate Proteins | 1 | 2006 | 59 | 0.020 |
Why?
| | Glycogen | 1 | 2006 | 55 | 0.020 |
Why?
| | Receptor, Insulin | 1 | 2006 | 105 | 0.020 |
Why?
| | Forecasting | 1 | 2008 | 387 | 0.020 |
Why?
| | Gene Expression | 1 | 2011 | 1501 | 0.020 |
Why?
| | Body Temperature | 1 | 2006 | 221 | 0.020 |
Why?
| | Endothelial Cells | 1 | 2011 | 779 | 0.010 |
Why?
| | Liver | 2 | 2010 | 1941 | 0.010 |
Why?
| | Lactic Acid | 1 | 2006 | 306 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 2007 | 812 | 0.010 |
Why?
| | Hospitals, University | 1 | 2004 | 183 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2006 | 365 | 0.010 |
Why?
| | Phosphoproteins | 1 | 2006 | 338 | 0.010 |
Why?
| | Nuclease Protection Assays | 1 | 2003 | 4 | 0.010 |
Why?
| | Acid-Base Equilibrium | 1 | 2003 | 28 | 0.010 |
Why?
| | Drinking | 1 | 2003 | 42 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2003 | 200 | 0.010 |
Why?
| | Terminology as Topic | 1 | 2004 | 216 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2003 | 86 | 0.010 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2006 | 455 | 0.010 |
Why?
| | Respiratory Mechanics | 1 | 2003 | 67 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2003 | 72 | 0.010 |
Why?
| | Placentation | 1 | 2002 | 45 | 0.010 |
Why?
| | Angiogenesis Inducing Agents | 1 | 2002 | 24 | 0.010 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2002 | 79 | 0.010 |
Why?
| | Galactosides | 1 | 2001 | 5 | 0.010 |
Why?
| | Lac Operon | 1 | 2001 | 44 | 0.010 |
Why?
| | Macaca | 1 | 2001 | 56 | 0.010 |
Why?
| | Microcirculation | 1 | 2002 | 146 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2608 | 0.010 |
Why?
| | 3T3 Cells | 1 | 2001 | 163 | 0.010 |
Why?
| | Stomach | 1 | 2001 | 110 | 0.010 |
Why?
| | Morphogenesis | 1 | 2002 | 166 | 0.010 |
Why?
| | Child | 2 | 2020 | 21999 | 0.010 |
Why?
| | Transgenes | 1 | 2001 | 180 | 0.010 |
Why?
| | Neovascularization, Physiologic | 1 | 2002 | 178 | 0.010 |
Why?
| | Glucose | 1 | 2006 | 1028 | 0.010 |
Why?
| | Species Specificity | 1 | 2002 | 585 | 0.010 |
Why?
| | Ligation | 1 | 2000 | 87 | 0.010 |
Why?
| | Physical Stimulation | 1 | 2000 | 65 | 0.010 |
Why?
| | Trachea | 1 | 2001 | 237 | 0.010 |
Why?
| | Hydrocarbons, Brominated | 1 | 1999 | 4 | 0.010 |
Why?
| | Esophagus | 1 | 2001 | 255 | 0.010 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2000 | 145 | 0.010 |
Why?
| | Muscle, Smooth | 1 | 2000 | 155 | 0.010 |
Why?
| | Indoles | 1 | 2001 | 410 | 0.010 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 1995 | 3710 | 0.010 |
Why?
| | Receptor, Endothelin A | 1 | 1997 | 65 | 0.010 |
Why?
| | Drug Evaluation, Preclinical | 1 | 1997 | 184 | 0.010 |
Why?
| | Blood Glucose | 1 | 2006 | 2182 | 0.010 |
Why?
| | Leukocyte Count | 1 | 1997 | 331 | 0.010 |
Why?
| | Cell Line | 1 | 2001 | 2841 | 0.010 |
Why?
| | Acidosis, Respiratory | 1 | 1995 | 3 | 0.010 |
Why?
| | Catheterization, Swan-Ganz | 1 | 1995 | 9 | 0.010 |
Why?
| | Central Venous Pressure | 1 | 1995 | 14 | 0.010 |
Why?
| | Cardiomegaly | 1 | 1997 | 175 | 0.010 |
Why?
| | Postoperative Period | 1 | 1997 | 344 | 0.010 |
Why?
| | Peptides, Cyclic | 1 | 1997 | 259 | 0.010 |
Why?
| | Prolapse | 1 | 1995 | 5 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2002 | 1163 | 0.010 |
Why?
| | Pulmonary Wedge Pressure | 1 | 1995 | 69 | 0.010 |
Why?
| | Tidal Volume | 1 | 1995 | 86 | 0.010 |
Why?
| | Vulva | 1 | 1995 | 24 | 0.010 |
Why?
| | Cardiac Output | 1 | 1995 | 164 | 0.010 |
Why?
| | Vasodilator Agents | 1 | 1997 | 331 | 0.010 |
Why?
| | Anesthesia, General | 1 | 1995 | 73 | 0.010 |
Why?
| | Lymphocytosis | 1 | 1994 | 11 | 0.010 |
Why?
| | Safety | 1 | 1997 | 343 | 0.010 |
Why?
| | Abdomen, Acute | 1 | 1994 | 21 | 0.010 |
Why?
| | General Surgery | 1 | 1997 | 169 | 0.010 |
Why?
| | Pressure | 1 | 1995 | 222 | 0.010 |
Why?
| | Catheterization, Peripheral | 1 | 1995 | 109 | 0.010 |
Why?
| | Vascular Resistance | 1 | 1995 | 372 | 0.010 |
Why?
| | Vagina | 1 | 1995 | 186 | 0.010 |
Why?
| | Oxazoles | 1 | 1971 | 37 | 0.010 |
Why?
| | Acute Disease | 1 | 1994 | 1009 | 0.010 |
Why?
| | Penicillins | 1 | 1971 | 59 | 0.010 |
Why?
| | Databases, Factual | 1 | 1997 | 1355 | 0.010 |
Why?
| | Chronic Disease | 1 | 1997 | 1788 | 0.010 |
Why?
| | Leukocytes | 1 | 1971 | 312 | 0.010 |
Why?
| | Respiratory Tract Infections | 1 | 1971 | 396 | 0.000 |
Why?
| | Mice | 1 | 2001 | 17774 | 0.000 |
Why?
| | Middle Aged | 1 | 2006 | 33310 | 0.000 |
Why?
| | Kidney | 1 | 1971 | 1467 | 0.000 |
Why?
| | Dicloxacillin | 1 | 1971 | 1 | 0.000 |
Why?
| | Evaluation Studies as Topic | 1 | 1971 | 180 | 0.000 |
Why?
| | Imidazoles | 1 | 1971 | 239 | 0.000 |
Why?
| | Administration, Oral | 1 | 1971 | 812 | 0.000 |
Why?
| | Child, Preschool | 1 | 1971 | 11080 | 0.000 |
Why?
|
|
Galan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|